Breaking News
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Personalized program of physical exercise effective in reversing functional decline in the elderly
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - Vision impairments may increase risk of falls in older adults
November 19, 2018 - Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease
November 19, 2018 - Marijuana prevention programs should focus on promoting mental wellbeing of youth
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
‘Hidden’ driver discovered that helps prime the anti-tumor immune response

‘Hidden’ driver discovered that helps prime the anti-tumor immune response

image_pdfDownload PDFimage_print
In this study, authors used an interdisciplinary approach, integrating systems biology with the immunology expertise. (Study authors Xingrong Du, Hongbo Chi and Jiyang Yu). Credit: St. Jude Children’s Research Hospital

Like exposing a crime boss whose authority has gone undetected, St. Jude Children’s Research Hospital scientists have identified a hidden driver that influences production of the T cells that fight cancer and infections. The study appears today as an advance online publication in the journal Nature.

The hidden drivers are kinases (enzymes) Mst1 and Mst2. Researchers showed Mst1 and Mst2 work together to regulate the function of different dendritic cell types (subsets). Dendritic cells are key regulators of the adaptive immune system, including the T cells that are central to cancer immunotherapy.

“Dendritic cells are crucial for activating the adaptive immune response, including priming anti-tumor T cells,” said Hongbo Chi, Ph.D., a member of the St. Jude Department of Immunology. “But regulation of the distinct functions of different dendritic cell subsets have been poorly understood. We wanted to change that.

“These findings provide clues for new treatment strategies for cancer or immune disorders by modulating the activity of dendritic cells to shape the immune response,” said Chi, who is co-corresponding author of the research with Jiyang Yu, Ph.D., an assistant member of the St. Jude Department of Computational Biology. Xingrong Du, Ph.D., a postdoctoral fellow in Chi’s laboratory, is the first author.

Taking a Systems Approach

A data-driven, systems biology algorithm called NetBID played a key role in the research. Yu and his colleagues developed NetBID, short for data-driven network-based Bayesian inference of drivers.

Yu and his team integrated gene expression, whole proteomics and phosphorylated proteomics data from Chi’s laboratory and other sources to reverse engineer biologic networks in mouse dendritic cells. Researchers used NetBID to analyze differences in networks of the different dendritic cell subtypes. To their surprise, Mst1/2 and the Hippo signaling pathway emerged as a key regulator of dendritic cell function and the T cell response.

“The Hippo pathway is known for regulating organ size in animals, not immune function in dendritic cells,” Chi said. Yu compared Mst1/2 to a crime boss whose role is concealed behind several layers of subordinates. “A data-driven systems approach gave us a way to find the hidden drivers that underlie the differential functions of the dendritic cell subsets,” Yu said.

A data-driven, systems biology algorithm called NetBID played a key role in the research. Yu and his colleagues developed NetBID, to analyze differences in networks of the different dendritic cell subtypes. An example of the NetBID network used for this study. Credit: Jiyang Yu / St. Jude Children’s Research Hospital

Interdisciplinary collaboration was essential to the research, Chi added.

Metabolism and Signaling

This study focused on dendritic cell subsets that have distinct effects on the immune system. One, CD8α+ dendritic cells, primes production of CD8 T cells central to fighting tumors and infections. The other, CD8α- dendritic cells, primes production of a different T cell subtype.

Researchers compared metabolic activity in the different dendritic cells and found that the CD8α+ dendritic cells were more metabolically active than CD8α- dendritic cells. They reached that conclusion by comparing oxygen metabolism in the cells’ power plants, mitochondria. Investigators also showed that manipulating metabolism affected CD8α+ dendritic cell function and T cell priming.

“While metabolism is known to be important generally in the immune response, this study defines, we believe for the first time, that not only is it important in dendritic cell function, but that the two dendritic cell subsets have distinct metabolism controlled by Hippo signaling,” Chi said. “In addition, we showed that manipulating metabolism directly affects function of the dendritic cell subset.”

Researchers also showed that Mst1/2 played a pivotal role in cytokine signaling, which is essential for priming T cells and ensuring a robust immune response. Cytokines are small secreted molecules that modulate the immune response.

Rather than working through the conventional signaling pathways, investigators showed that Mst1/2 takes an unconventional route to prime T cells. Mst1/2 uses the NF-κB signaling pathway rather than convention pathways to trigger production of the cytokine interleukin-12 (IL-12). IL-12 promotes CD8α+ dendritic cell function and primes CD8 T cell responses.

“The research shows that Mst1/2 integrate metabolic activity and cytokine signaling to selectively drive CD8α+ dendritic cell function,” Chi said.

“The NetBID algorithm can be used to mine other datasets for hidden drivers and explore biological questions,” Yu said. “The algorithm has already been used to analyze network differences among different cancer subtypes or between drug-resistant and sensitive cancer patients for identification of potential therapeutic targets and biomarkers. The key is data-driven and context-specific networks,” he said.


Explore further:
Study provides insights on immune cells involved in kidney disease

More information:
Hippo/Mst signaling couples metabolic state and immune function of CD8a+dendritic cells, Nature (2018). DOI: 10.1038/s41586-018-0177-0 , www.nature.com/articles/s41586-018-0177-0

Journal reference:
Nature

Provided by:
St. Jude Children’s Research Hospital

Tagged with:

About author

Related Articles